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Abstract
Background: Resistance to programmed cell death (apoptosis) is a crucial factor for the carcinogenesis of oral 
squamous cell carcinoma (OSCC). Vitamin D (calcitriol) may overcome apoptosis resistance in tumor cells of 
OSCC. Vitamin D receptor (VDR) expression in oral precancerous lesions of OSCC has not been analyzed and 
serum vitamin D level seems to be a predictor of cancer development.
Material and Methods: Expression of VDR was analyzed in normal oral mucosa (n=5), oral precursor lesions 
(simple hyperplasia, n=11; squamous intraepithelial neoplasia, SIN I-III, n=35), and OSCC specimen (n=42) by 
immunohistochemistry (IHC). Moreover, serum vitamin D levels were measured by 25(OH)D3 (calcidiol) in pa-
tients with OSCC (n=42) and correlated with IHC results.
Results: Expression of VDR was significantly increased in precancerous and OSCC compared with normal tissue. 
Compared with SIN I-III lesions VDR expression significantly decreased in OSCC. Severe vitamin D deficiency 
was detected in our OSCC patient cohort but there was no significant correlation analyzed between serum vitamin 
D levels and corresponding immunohistochemically detected VDR expression in OSCC. 
Conclusions: Our survey provides the first evidence of VDR expression in precancerous lesions of OSCC. Apop-
tosis induction of VDR+ cells in oral precancerous lesions and OSCC by natural vitamin D or synthetic vitamin D 
compounds could be useful for chemoprevention. Moreover, systemically and/or locally applied, these compounds 
may act as sensitizers for apoptosis mediated by radio-, and chemotherapy treatment in OSCC.
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Introduction 
The development of oral squamous cell carcinoma 
(OSCC) is a multistep process that influence key cellular 
pathways involved in tumor development and growth. A 
diversity of endogenous and exogenous stimuli is lead-
ing to a complex series of molecular changes participat-
ing in cancer development (1,2). The subsequent rise of 
malignant tumors from a single transformed cell and the 
development through detectable precancerous stages is 
described by the model of multistep carcinogenesis (3). 
This fact depicts the need for continued efforts to dis-
cover new biomarkers for the early OSCC diagnosis and 
therapy as well as for the improved understanding of 
disease pathogenesis as a first step towards improving 
treatment. The pace of clinical translation in the field of 
molecular translational oncology has accelerated in the 
last few years. Analyzing the mechanistic basis of the 
multistep process potentially allows the development 
of molecular tools to manipulate oral carcinogenesis, 
which is relevant to the practicing oncologist.
OSCC is a major cause of morbidity and mortality 
worldwide with low response to chemotherapy and ba-
sic resistance to most standard anticancer drugs (4,5). 
The process of programmed cell death (apoptosis) that 
may occur in multicellular organisms is a genetically 
regulated cell death involved in the deletion of cells in 
normal as well as malignant tissues (6). Resistance to 
apoptosis (7) is known as a crucial factor for the car-
cinogenesis of OSCC, which is associated with tumor 
recurrence as well as radio-,  and chemotherapy resist-
ance (8,9). Therefore, overcoming apoptosis resistance 
is a major aim in the treatment of OSCC.
In a number of cell types, the antineoplastic activity of 
1,25-dihydroxyvitamin D3 (1,25-(OH)2D3, calcitriol) 
contributes to the induction of apoptosis, inhibition of 
invasiveness, and angiogenesis (10,11). The antineoplas-
tic activity of 1,25-(OH)2D3 was shown in-vitro and in-
vivo in a wide variety of malignancies including head 
and neck cancer (12-18) and specifically OSCC (19-21). 
Moreover, the effectiveness of cytostatic chemotherapy 
to induce apoptosis in OSCC cells is enhanced by cal-
citriol (21). 
In general, the measurement of serum calcidiol is a bet-
ter predictor of cancer development than calcitriol (1,25 
(OH)2D3) (22,23). Studying serum vitamin D level and 
its corresponding vitamin D receptor (VDR) seems to 
be reasonable for guiding supportive treatment of pa-
tients with precancerous lesions and OSCC. 
Recently, we have demonstrated low VDR expression 
as an adverse prognostic factor for the survival of pa-
tients with OSCC (11). However, the expression of VDR 
in different precancerous lesions has not been described 
yet. Therefore, the purpose of this study was to inves-
tigate VDR expression in precancerous lesions. Moreo-
ver, serum vitamin D levels (calcidiol) were measured 
and correlated with tissue-related VDR expression in 
OSCC patients.
Material and Methods
- Patients and Tumor Specimen 
The records of healthy individuals (normal oral mucosal 
tissues, n=5), patients with oral precursor lesions (sim-
ple hyperplasia, n=11; squamous intraepithelial neopla-
sia SIN I, n=5; SIN II, n=9; SIN III, severe dysplasia, 
n=10; SIN III, carcinoma in situ, n=11), and patients with 
invasive OSCC (n=42, Table 1) were retrospectively as-
sessed from January 2009 to December 2013. Out of 
these 42 precursor lesions, 4 specimens were clinically 
and histopathologically classified as oral lichen planus 
and 38 specimens presented as leukoplakia. The diag-
nosis of normal oral mucosal tissues, precursor lesions, 
and invasive squamous cell carcinoma was confirmed 
by the department of Pathology, University Hospital 
Tuebingen. The material was archival formalin-fixed, 
Characteristics Number of Patients 
Total n=42 
Gender 
Male 24 
Female 18 
Histological Grading 
G1 7 
G2 25 
G3 9 
G4 1 
Depth of invasion 
pT1 10 
pT2 11 
pT3 5 
pT4 16 
Cervical lymph node metastasis 
pN0 26 
pN1 4 
pN2 10 
pN3 2 
UICC stage
UICC I 8 
UICC II 4 
UICC III 6 
UICC IV 24 
Distant metastasis 
yes 2 
no 40 
Site distribution of OSCC 
Tongue 10  
Floor of the mouth 20 
Palate 5  
Buccal mucosa 1  
Alveolar ridge 6  
Table 1. Clinicopathological characteristics of 42 patients with 
OSCC. 
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paraffin-embedded tissue from routine histopathologi-
cal work-ups. The material has been stored with per-
mission of the local ethics committee of the University 
Hospital Tuebingen (approval number: 562-2013BO2), 
after informed consent obtained from the patients prior 
to surgical resection. Tumor blocks of paraffin-embed-
ded tissue were selected by experienced pathologists, 
evaluating the routine H&E stained sections. Sections 
from all available tissues underwent histopathological 
assessment, blinded to the prior histopathology report. 
Serial tissue sections (2 µm thickness) were cut from 
formalin-fixed paraffin-embedded (FFPE) blocks on 
a microtome and mounted from warm water onto ad-
hesive microscope slides. First, we assessed H&E sec-
tions from each tissue section to differentiate between 
normal tissue, precursor lesions, tumor cell areas, stro-
mal areas, and infiltrating immune cells. Oral precursor 
lesions were classified according to WHO criteria (3). 
Tumor staging was performed according to the 7th edi-
tion of the TNM staging system by the UICC/ AJCC of 
2010. Grading of OSCC was defined according to WHO 
criteria.
- Staining procedure and quantification of immunohis-
tochemistry
We stained for VDR (LifeSpan Biosciences, Eching, 
Germany, rabbit anti-human VDR pAb, LS-B2976, di-
lution: 1:100, (11) in tissue sections. Staining was per-
formed on serial sections of 2µm thickness, which were 
deparaffinized in xylene and ethanol and rehydrated in 
water. Heat induced epitope retrieval (HIER) was per-
formed with citrate buffer pH 6.0 (Dako, Hamburg, Ger-
many). Endogenous peroxidase activity was quenched 
with 0.3% hydrogen peroxide. Endogenous biotin ac-
tivity was blocked using the avidin/biotin blocking kit 
(Vector Laboratories, Burlingame, CA, USA). After in-
cubation with the primary or control antibody the Dako 
LSAB2 peroxidase System (Dako, Hamburg) was used. 
Slides were subsequently incubated for 5 minutes in 
DAB (3,3’-diaminobenzidine, Biogenex) counterstained 
with haemalaun and mounted with Glycergel (Dako). 
Five representative high power fields (1 HPF = 0.237 
mm2, original magnification: x200-fold) were analyzed 
for VDR expression in normal tissue, oral precursor le-
sions, tumor tissue and averaged, respectively. The ex-
tent of the staining, defined as the percentage of positive 
staining areas of tumor cells in relation to the whole tis-
sue area, was semi-quantitatively scored on a scale of 0 
to 3 as the following: 0, <10%; 1, 10–30%; 2, 30-60%; 3, 
>60%. The intensities of the signals were scored as 1+, 
2+, and 3+. Then, a combined score (0–9) for each spec-
imen was calculated by multiplying the values of these 
two categories (24). Cases were classified as negative, 
0 points, positive, 1-9 points. Two observers blinded to 
the diagnosis performed scoring on identical sections 
marked by circling with a water-resistant pencil and fi-
nally with diamond-tipped pencil on the opposite side 
of the microscopic slide. Pictures were analyzed using a 
Canon camera (Krefeld, Germany). The photographed 
images were imported into the Microsoft Office Picture 
Manager. 
- Measurement of serum 25(OH)D3 (Calcidiol) concen-
trations in patients with OSCC
From patients with invasive OSCC (n=42), in each case, 
serum samples were obtained in the preoperative pe-
riod and stored at -80°C until 25(OH)D3 was measured. 
Serum 25(OH)D3 levels were measured twice by radio-
immunoassay at Biovis laboratory (Limburg-Offheim, 
Germany). History of cancer patients gave no indication 
for severe kidney or hepatic dysfunction. Serum levels 
>35 ng/ml, 25-35 ng/ml, 12.5-25 ng/ml and <12.5 ng/ml 
were considered as normal, mild, moderate and severe 
vitamin D deficiency, respectively (25).
- Statistical analysis
Statistical analysis was performed with MedCalc Soft-
ware, Version 13.1.1 (Mariakerke, Belgium). Data were 
analyzed using the non-parametric Mann-Whitney U 
Test or Kruskal-Wallis test when more than 2 groups 
were compared. Correlation analysis of immunohisto-
chemically detected VDR expression with serum 25(OH)
D3 was performed by the non-parametric Kendall’s tau 
(τ) coefficient. All p-values presented were 2-sided and 
p < 0.05 was considered statistically significant.
 
Results
- VDR expression in normal mucosa, oral precursor le-
sions and OSCC
VDR was found expressed in all tissue types (Fig. 1 and 
2), normal oral mucosa (n=5/5), oral precursor lesions 
(simple hyperplasia, n=11/11; squamous intraepithelial 
neoplasia, SIN I-III, n=35/35), and OSCC specimen 
(n=42/42). In comparison to normal tissue a significantly 
(p < 0.05) increased expression of VDR (Fig. 1 and 2) 
was observed in tumor cells of OSCC. Compared with 
SIN I-III VDR expression was significantly decreased 
in OSCC (Fig. 1 and 2). 
- Serum 25(OH)D3 (calcidiol) values in patients with 
OSCC and correlation with corresponding immunohis-
tochemically detected VDR expression 
No patient (n=0/42, 0%) showed normal (>35 ng/ml) 
serum vitamin D levels or mild (25-35 ng/ml) vitamin D 
deficiency. In 16 out of 42 patients (n=16/42, 38%) mo-
derate (12.5-25 ng/ml) vitamin D deficiency was analy-
zed and in 26 out of 42 patients (n=26/42, 62%) severe 
(<12.5 ng/ml) vitamin D deficiency was detected. The 
mean serum vitamin D level was measured at 12.2 ng/
ml (range: 4.0-19.9 ng/ml) in all OSCC patients. 
There was no significant correlation found between 
serum 25(OH)D3 values and corresponding immuno-
histochemically detected VDR expression in patients 
with OSCC (n=42): т = 0.114, p = 0.2916.
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Discussion
In our survey, we analyzed for the first time VDR ex-
pression in different precancerous lesions of OSCC. In 
patients with OSCC corresponding vitamin D levels 
were investigated and correlated with immunohisto-
chemical VDR expression. We analyzed increased ex-
pression of VDR in OSCC compared with normal oral 
mucosa. However, compared with SIN I-III VDR ex-
pression was significantly decreased in OSCC. 
To explain tumor heterogeneity and inherent differen-
ces of tumor-regenerating capacity two cancer models 
are described (26). The clonal selection model of mul-
tistep carcinogenesis describes that a random solitary 
cell undergoes malignant transformation, accumulates 
multiple mutations and subsequently acquires a survi-
val advantage, which leads to clonal selection (27,28). In 
contrast, the cancer stem cell (CSC) hypothesis hypo-
thesis regards malignant transformation as a process, 
occurring in a subset of normal stem cells with pluripo-
tent properties, which underlie deregulation of self-re-
newal pathways (29,30). Although VDR expression has 
not been described as a classical CSC marker, putative 
CSC of the breast (31,32) and OSCC (11) express this 
receptor. CSCs themselves may undergo clonal evolu-
tion and therefore, both models are not mutually exclu-
sive (33,34). Our results of decreased VDR expression 
in OSCC compared with SIN lesions can be explained 
with the clonal selection model of carcinogenesis, which 
proposes that there is a subsequent clonal selection of 
cancer cells or putative CSC during carcinogenesis (26, 
32,35). These CSC are resistant to standard adjuvant 
therapeutic approaches. Enhancing apoptosis in precur-
sor and tumor cells is a key event for cancer therapy and 
chemoprevention (36). In this connection, natural vita-
min D or synthetic vitamin D compounds (10,37) have 
been demonstrated for induction of apoptosis and play 
an emerging role in cancer therapy. Several studies have 
suggested a link between low serum vitamin D levels 
Fig. 1. Immunohistochemical staining of VDR in OSCC. Immuno-
histochemical staining shows representative images of VDR in N.T. 
(A), SIN (B), and OSCC (C). Brown chromogen color (3,3'-Diamin-
obenzidine) indicates positive staining, the blue color shows the nu-
clear counterstaining by hematoxylin. The square box demonstrates 
the area of interest (original magnification: x100-fold, left panel) 
which is also shown in larger magnification (x200-fold, right panel). 
VDR, vitamin D receptor; SIN, squamous intraepithelial neoplasia; 
N.T., normal tissue.
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and an increased risk of cancer (38,39), overall with the 
strongest evidence for breast and colorectal cancer. Mo-
reover, higher vitamin D intake is linked with a lower 
risk for breast cancer (40). Recent data indicate that the 
safe upper intake level for Calcitriol is 10,000 IU/d (41), 
which is substantially more potent than ergocalciferol 
(vitamin D2). Authors assume that induction of apop-
tosis in VDR+ precancerous lesions (e.g. leukoplakia 
or oral lichen planus) and tumors by vitamin D could 
be useful for chemoprevention or may act as sensiti-
zers for apoptosis in the treatment of OSCC (37). This 
hypothesis has to be evaluated in clinical studies. In a 
Murine Model of Cutaneous Squamous Cell Carcinoma 
oral calcitriol supplementation enhanced Photodyna-
mic therapy-induced tumor cell death (42). Therefore, 
topical and/or systemically applicated vitamin d (or in 
Fig. 2. Immunohistochemical analysis of VDR in normal oral mucosal tissue, oral precursor lesions - hy-
perplasia, SIN, and invasive OSCC. In comparison with normal tissue a significantly increased expression 
of VDR is observed in hyperplasia, SIN I - SIN III lesions, and OSCC (p < 0.05, Kruskal-Wallis Test; A 
and B). In comparison with SIN I, SIN II, and SIN III (sev. dysplasia) a significantly decreased expression 
of VDR is observed in OSCC. VDR expression is significantly decreased in OSCC compared with SIN I-III 
(p < 0.0001, Mann-Whitney U Test). Analysis refers to averaged scores. Red line indicates VDR expression 
results in carcinogenesis. Grey lines show 95% confidence intervals. Analysis of significant statistically 
different single values is indicated in the table below (B). SIN III is subdivided in severe dysplasia and 
carcinoma in situ (CIS). VDR, vitamin D receptor; SIN, squamous intraepithelial neoplasia; N.T., normal 
tissue.
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combination with vitamin A derivates (21) may be con-
sidered as a possible new, non-toxic, adjuvant cancer 
therapy, which can be easily introduced into the classic 
protocols of clinical cancer therapy without any supple-
mentary risk for VDR+ patients. With specific regard 
to the hypothesis of the field cancerization (43,44) sys-
temically applicated vitamin d seems very meaningful 
as the tissue of the gastrointestinaltract is exposed to 
the two main exogenous carcinogenic factors, tobacco 
and alcohol (45). If the carcinogenic stimuli continue, 
second metachronous tumors in related sites may occur 
(45).
From our results, we don t´ know whether increased 
VDR expression in oral precancerous or OSCCs exhi-
bits a functionally inactivating mutation and this may 
be due to a feedback loop coupled with an expression by 
the tumour cells of a defective VDR (46). In different 
cell types, Calcitiol has been shown to enhance VDR 
expression on gene and protein level in vitro (47,48). It 
has been assumed that the increase of VDR expression 
following calcitriol administration is due to an increa-
sed receptor protein lifetime (48) and/or elevated trans-
cription of VDR genes (49) The study by Lehmann et 
al. indicated that human keratinocytes may have the 
capacity to hydroxylate vitamin D at the C-1 and C-25 
positions (50). Keratinocytes could be able to synthesize 
the biologically active calcitriol, therefore. However, we 
don t´ know if oral precancerous or OSCCs are able to 
synthesize calcitriol as well. It can be speculated whe-
ther the increased content of VDR on the mRNA and 
protein levels that we have shown in this study is due 
to an increased formation of calcitriol in these tumour 
cells. Moreover, inflammatory peptides/cytokines ex-
pressed by tumour-infiltrating leucocytes and oral pre-
cancerous/tumor cells may upregulate VDR expression 
in adjacent cells (51).
Overall, the vitamin D status may be associated with di-
sease-free survival and overall survival time in patients 
with squamous cell carcinoma of the upper aerodiges-
tive tract (52). Evidence from the literature suggests the 
relationship between serum calcidiol concentration and 
cancer prevention as an optimal level of 80 nmol/L (~32 
ng/ml) (22,41). Based on the literature review on vita-
min D status in the Central Europe (CE) populations, it 
can be concluded that 25-OH vitamin D levels are on 
average below the 30 ng/mL level. In wintertime 25-OH 
vitamin D values of the CE population are close to 21-
23 ng/mL for all studied age groups, with a significant 
increase of 25-OH vitamin D in August reaching 42 ng/
mL for those aged 0-9 years, but only 21 ng/mL for the 
elderly aged 80-89 years (53). Focusing on head and 
neck squamous cell carcinoma (HNSCC), a previous 
study by Arem et al. (54) anaylzed a median serum 25-
OH vitamin D level at 31 nmol/L (~12 ng/ml) without 
association of oropharynx cancer in Finnish men (inclu-
ding n=131 patients with OSCC). Our results are well in 
line with the results by Arem et al. (54) demonstrating a 
severe vitamin D deficiency in our patient cohort (mean 
serum vitamin D level 12.2 ng/ml), which is lower com-
pared with `normal´ CE population as described by Plu-
dowski et al above (53).
However, a previous published study by Yuan et al. (55) 
strongly supports a crucial role for vitamin D signa-
ling in oral keratinocyte pathophysiology in-vitro and 
in-vivo but vitamin D deficiency alone seems to be in-
sufficient to alter oral epithelial homeostasis and pro-
voke carcinogenesis. Afzal et al. (56) demonstrated a 
low plasma 25-hydroxyvitamin D level with increased 
risk of tobacco-related cancer including HNSCC. In this 
context vitamin D may conversely modify the carcino-
genicity of tobacco smoke chemicals. Authors hypothe-
size that especially smokers my benefit from Vitamin D 
intake as more than 80% of OSCC are associated with 
tobacco abuse. 
Oral keratinocytes are able to synthesize the biologica-
lly active calcitriol. The steroid hormone responsiveness 
is directly proportional to the number of corresponding 
receptors (47). Therefore, we perfomed correlation 
analysis of serum vitamin d levels and the correspon-
ding VDR in the tumor tissue of OSCC patients but the 
data did not show any significant correlation. This can 
be explained as many cytokines and inflammatory pep-
tides excreted by tumour-infiltrating leucocytes as well 
as tumour cells may influence VDR expression (51).
As suggested for multistep carcinogenesis (2) it is un-
clear based on the actual literature whether vitamin d 
can be standardized effective for chemoprevention in 
the treatment of precursor lesions or OSCC develop-
ment but it provides a clear rational for further studies 
in the carcinogenesis of OSCC. 
Conclusions 
Our survey provides the first evidence of VDR expres-
sion in of OSCC. Apoptosis induction of VDR+ cells in 
oral precancerous lesions and OSCC by natural vitamin 
D or synthetic vitamin D compounds (10) could be use-
ful for chemoprevention. Moreover, systemically and/or 
locally applied, these compounds may act as sensitizers 
for apoptosis mediated by radio-, and chemotherapy 
treatment in OSCC.
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